HALOZYME THERAPEUTICS SC 13D 5-15-2007

Company

HALOZYME THERAPEUTICS, INC.

Filed

May 24, 2007

Accession Number

0001140361-07-010891

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →